ICS 2018 Scientific Podium Short Oral Session S33

Overactive Bladder 2

Scientific Podium Short Oral Session S33

Speakers
	Friday 31st August 2018
	14:35 - 16:05
	Hall C Capacity: 250
A Angie Rantell ICS Chair R Roger Roman Dmochowski ICS Chair A Alan J Wein ICS Chair

Session Schedule

14:35

#643 Do abnormal toileting behaviors contribute to worse urinary symptoms in women?

Kowalik C G¹, Daily A¹, Delpe S¹, Kaufman M R¹, Dmochowski R¹, Reynolds W S¹
1. Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, TN, USA
Female, Overactive Bladder, Questionnaire, Voiding Dysfunction

14:42

#644 Trends in the Utilization of Third Line Treatment Modalities for Overactive Bladder

Drangsholt S¹, Slawin J¹, Brucker B M¹
1. New York University
Neuromodulation, Overactive Bladder, Outcomes Research Methods

14:50

#645 The effectiveness of nurse-delivered Botulinum toxin-A injections with flexible cystoscopy under local anaesthetic to treat female idiopathic overactive bladder.

Smith G¹, Bolderson J¹, Lane S², Trochez R¹
1. Liverpool Women's Hospital NHS Trust, 2. University of Liverpool
Female, Overactive Bladder, Urgency Urinary Incontinence

14:57

#646 A single procedure of Selective Bladder Denervation (SBD) of the trigone in patients with overactive bladder (OAB) appears to result in symptom improvement for 12 months

Rovner E¹, Tu L², De Wachter S G³, Versi E⁴, Dmochowski R⁵
1. Medical University of South Carolina, USA, 2. Sherbrooke University Hospital, Canada, 3. University of Antwerp, Belgium, 4. Rutgers Robert Wood Johnson Medical School, NJ, USA, 5. Vanderbilt University, USA
Overactive Bladder, New Devices, Clinical Trial, Female, Sensory Dysfunction

15:05

#647 Understanding the relationship between anterior vaginal compartment prolapse and overactive bladder

Diez-Itza I¹, Martín-Martínez A², Uranga S¹, Avila M¹, Lekuona A¹, García-Hernández J A²
1. Hospital Universitario Donostia. San Sebastian. Spain, 2. Complejo Hospitalario Universitario Insular Materno Infantil. Las Palmas de Gran Canaria. Spain
Overactive Bladder, Pelvic Organ Prolapse, Anatomy

15:12

#648 Efficacy of tadalafil monotherapy and associations between changes in subjective overactive bladder symptoms and changes in oxidative stress in patients with lower urinary tract symptoms

Matsuo T¹, Miyata Y¹, Araki K¹, Nakamura Y¹, Sagara Y¹, Ohba K¹, Sakai H¹
1. Nagasaki University Hospital
Overactive Bladder, Prospective Study, Male, Gerontology

15:20

#649 Early and Consistent Improvements in Urinary Symptoms and Quality of Life in Idiopathic Overactive Bladder Patients Following Repeat Treatment With OnabotulinumtoxinA: Results of a Multicenter, Randomized, Placebo-Controlled, Phase 4 Trial

McCammon K¹, Gousse A², Gruenenfelder J³, Hale D⁴, Orejudos A⁵, Patel A⁶, Kohan A⁷
1. Eastern Virginia Medical School, Norfolk, VA, USA, 2. Memorial Hospital Miramar, Miramar, FL, USA, 3. Orange County Urology Associates, Laguna Hills, CA, USA, 4. Urogynecology Associates, PC, Indianapolis, IN, USA, 5. Allergan plc, Irvine, CA, USA, 6. Allergan plc, Marlow, UK, 7. Advanced Urology Centers of New York, Bethpage, NY, USA
Incontinence, Overactive Bladder, Urgency/Frequency

15:27

#650 Is the ice water test associated with anticholinergic resistance in patients with idiopathic overactive bladder?

Waterschoot M¹, Uvin P¹, Everaerts W², Raskin Y¹, Voets T³, Van Oudenhove L⁴, Van der Aa F², van den Heijkant M⁵
1. Department of Urology, University of Leuven, 2. Department of development and regeneration, organ systems, Experimental Urology, University of Leuven, 3. Laboratory of Ion Channel Research, Department of Cellular and Molecular Medicine, University of Leuven & VIB Center for Brain & Disease Research, Leuven, 4. Translational Research Center for Gastrointestinal Disorders (TARGID), Department of Clinical & Experimental Medicine, University of Leuven, Belgium & University Psychiatric Centre KU Leuven, Leuven, 5. Department of Urology, Department of pediatric Urology, University of KU Leuven
Overactive Bladder, Detrusor Overactivity, Prospective Study, Urodynamics Techniques, Questionnaire

15:35

#651 Do overactive bladder symptoms exhibit a Gaussian distribution? Implications for reporting of clinical trial data

Amiri M¹, Murgas S², Michel M C³
1. University of Duisburg-Essen, 2. Apogepha, 3. Johannes Gutenberg University
Overactive Bladder, Outcomes Research Methods, Prospective Study, Pharmacology, Incontinence

15:42

#652 Patients have poor compliance with repeat OnabotulinumtoxinA injections for overactive bladder

Nguyen A¹, Tam J², Du C¹, Wang Q¹, Hung M², Kim J²
1. Stony Brook University School of Medicine, 2. Stony Brook University Medical Center Department of Urology
Overactive Bladder, Detrusor Overactivity, Urgency/Frequency, Voiding Dysfunction , Retrospective Study

15:50

#653 OAB symptoms: Momentary digital assessment, a solution to unmet clinical needs, using a real life symptom evaluation.

Herrewegh A¹, Vrijens D¹, Kruimel J², Leue C³, van Koeveringe G¹
1. Maastricht University Medical Center+, Department of Urology, Pelvic Care Center, 2. Maastricht University Medical Center+, Division of Gastroenterology-Hepatology, Department of Internal Medicine, 3. Maastricht University Medical Center+, Department of Psychiatry and Medical Psychology
Overactive Bladder, Questionnaire, Terminology, Quality of Life (QoL), Pathophysiology

15:57

#654 Evidence-based management of overactive bladder patients: Expectation to become symptom-free

Michel M C¹, Murgas S², Oelke M³, Schneider T⁴
1. Johannes Gutenberg University, 2. Apogepha, 3. St Antonius Hospital, 4. Praxis-Klinik Rhein-Ruhr
Overactive Bladder, Outcomes Research Methods, Clinical Trial, Pharmacology